Page 60 - Read Online

Méndez-Sánchez et al. Hepatoma Res 2020;6:5 I http://dx.doi.org/10.20517/2394-5079.2019.29 Page 11 of 13

Alcohol Alcohol Suppl 1994;2:157-62.
11. Ganne-Carrié N, Nahon P. Hepatocellular carcinoma in the setting of alcohol-related liver disease. J Hepatol 2019;70:284-93.
12. Zhong Z, Lemasters JJ. A unifying hypothesis linking hepatic adaptations for ethanol metabolism to the proinflammatory and
profibrotic events of alcoholic liver disease. Alcohol Clin Exp Re 2018;42:2072-89.
13. Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, et al. The role of dynamin-related protein 1, a mediator of
mitochondrial fission, in apoptosis. Dev Cell 2001;1:515-25.
14. Palma E, Riva A, Moreno C, Odena G, Mudan S, et al. Perturbations in mitochondrial dynamics are closely involved in the
progression of alcoholic liver disease. Alcohol Clin Exp Res 2020; Epub ahead of print [PMID: 32020641 DOI: 10.1111/acer.14299]
15. Seitz HK, Korsten MA, Lieber CS. Ethanol oxidation by intestinal microsomes: increased activity after chronic ethanol administration.
Life Sci 1979;25:1443-8.
16. Pronko P, Bardina L, Satanovskaya V, Kuzmich A, Zimatkin S. Effect of chronic alcohol consumption on the ethanol- and
acetaldehyde-metabolizing systems in the rat gastrointestinal tract. Alcohol Alcohol 2002;37:229-35.
17. Teschke R. Review article. Biochemical aspects of the hepatic microsomal ethanol-oxidizing system (MEOS): resolved initial
controversies and updated molecular views. Biochem Pharmacol (Los Angel) 2019;8:267.
18. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature
2012;489:220-30.
19. Sender R, Fuchs S, Milo R. Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell
2016;164:337-40.
20. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, et al. A human gut microbial gene catalogue established by metagenomic sequencing.
Nature 2010;464:59-65.
21. Cardona F, Andrés-Lacueva C, Tulipani S, Tinahones FJ, Queipo-Ortuño MI. Benefits of polyphenols on gut microbiota and
implications in human health. J Nutr Biochem 2013;24:1415-22.
22. Stärkel P, Leclercq S, de Timary P, Schnabl B. Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and
alcoholic liver disease. Clin Sci 2018;132:199-212.
23. Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol
2009;124:3-20; quiz 21-2.
24. Kim YS, Ho SB. Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr Gastroenterol Rep
2010;12:319-30.
25. Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci 2019;76:473-93.
26. Varela-Rey M, Woodhoo A, Martinez-Chantar ML, Mato JM, Lu SC. Alcohol, DNA methylation, and cancer. Alcohol Res 2013;35:25-35.
27. Fabris C, Toniutto P, Falleti E, Fontanini E, Cussigh A, et al. MTHFR C677T polymorphism and risk of hcc in patients with liver
cirrhosis: role of male gender and alcohol consumption. Alcohol Clin Exp Res 2009;33:102-7.
28. Saffroy R, Pham P, Chiappini F, Gross-Goupil M, Castera L, et al. The MTHFR 677C > T polymorphism is associated with an
increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis. Carcinogenesis 2004;25:1443-8.
29. Lu SC, Mato JM. Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer. Alcohol
2005;35:227-34.
30. Teschke R. Alcoholic liver disease: alcohol metabolism, cascade of molecular mechanisms, cellular targets, and clinical aspects.
Biomedicines 2018;6.
31. Hu W, Feng Z, Eveleigh J, Iyer G, Pan J, et al. The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially
forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. Carcinogenesis
2002;23:1781-9.
32. Wang Y, Tong J, Chang B, Wang B, Zhang D, et al. Effects of alcohol on intestinal epithelial barrier permeability and expression of
tight junction-associated proteins. Mol Med Rep 2014;9:2352-6.
33. Bull-Otterson L, Feng W, Kirpich I, Wang Y, Qin X, et al. Metagenomic analyses of alcohol induced pathogenic alterations in the
intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment. PLoS One 2013;8:e53028.
34. Wang Y, Kirpich I, Liu Y, Ma Z, Barve S, et al. Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor,
promotes intestinal integrity and ameliorates alcohol-induced liver injury. Am J Pathol 2011;179:2866-75.
35. Bajaj JS, Kakiyama G, Zhao D, Takei H, Fagan A, et al. Continued alcohol misuse in human cirrhosis is associated with an impaired
gut-liver axis. Alcohol Clin Exp Res 2017;41:1857-65.
36. Bajaj JS, Heuman DM, Hylemon PB, Sanyal AJ, White MB, et al. Altered profile of human gut microbiome is associated with
cirrhosis and its complications. J Hepatol 2014;60:940-7.
37. Mutlu EA, Gillevet PM, Rangwala H, Sikaroodi M, Naqvi A, et al. Colonic microbiome is altered in alcoholism. Am J Physiol
Gastrointest Liver Physiol 2012;302:G966-78.
38. Wang L, Fouts DE, Stärkel P, Hartmann P, Chen P, et al. Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing
mucosa-associated microbiota and preventing bacterial translocation. Cell Host Microbe 2016;19:227-39.
39. Chen P, Stärkel P, Turner JR, Ho SB, Schnabl B. Dysbiosis-induced intestinal inflammation activates TNFRI and mediates alcoholic
liver disease in mice. Hepatology 2015;61:883-94.
40. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, et al. Changes in gut microbiota control inflammation in obese mice
through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009;58:1091-103.
41. Bode C, Kugler V, Bode JC. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of
chronic liver disease following acute alcohol excess. J Hepatol 1987;4:8-14.
42. Fukui H, Brauner B, Bode JCh, Bode Ch. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease:
reevaluation with an improved chromogenic assay. J Hepatol 1991;12:162-9.